Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04589052 · ClinicalTrials.gov registry record
Identification of Anxiety and Depression in Adolescents/Young Adults (AYA) With Cancer
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT04589052: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT04589052 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04589052 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This is a prospective, multisite (but all within the UTSW IRB), observational study assessing the relationship of hope to anxiety and depression, QoL, and social support over time in the first year after cancer diagnosis or relapse in AYA (ages 15-29 years of age).
Primary Outcome
* Hypothesis a: Greater than 50% of eligible patients will enroll and complete at least two time points in the study. * Hypothesis b: Enrollment and study completion rates will differ by site, with the site with the most psychosocial risk (low socioeconomic status as measured by insurance type (private, public, uninsured)) having the lowest enrollment and study completion rates. * Hypothesis c: Enrollment and study completion rates will differ by treatment type. Those receiving treatment that ha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2023-11-01 |
What the finished NCT04589052 record still lists
NCT04589052 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04589052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04589052 about?
NCT04589052 is a clinical study titled "Identification of Anxiety and Depression in Adolescents/Young Adults (AYA) With Cancer". This is a prospective, multisite (but all within the UTSW IRB), observational study assessing the relationship of hope to anxiety and depression, QoL, and social support over time in the first year after cancer diagnosis or relapse in AYA (ages 15-29 years of age).
What is the current status of trial NCT04589052?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2020-10-05. Estimated completion is 2023-11-01.
Who is sponsoring clinical trial NCT04589052?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI